The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
HSPB9, encoded by the gene located at chromosomal position 17q21.2 in humans, produces a small heat shock protein of approximately 17.5 kDa (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3). The protein is also designated as Cancer/Testis antigen 51 (CT51) and belongs to the small heat shock protein (HSPB/HSP20) family, which is characterized by a conserved α-crystallin domain flanked by variable N-terminal and C-terminal regions (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5). Among the human small heat shock protein family members (HSPB1-HSPB10), HSPB9 stands out as one of the least characterized proteins (tedesco2022insightsonhuman pages 13-14).
Small heat shock proteins (sHSPs) function as ATP-independent molecular chaperones that maintain cellular protein homeostasis by preventing protein aggregation (tedesco2022insightsonhuman pages 2-5, vos2008structuralandfunctional pages 3-5). The defining structural feature of this family is the conserved α-crystallin domain (ACD), also known as the HSP20 domain, which mediates oligomerization and substrate recognition (tedesco2022insightsonhuman pages 2-5, vos2008structuralandfunctional pages 3-5). HSPB9 possesses this conserved α-crystallin domain, indicating its membership in this chaperone family (tedesco2022insightsonhuman pages 2-5).
Based on family membership, HSPB9 is predicted to share the typical sHSP architecture comprising three regions: a variable N-terminal domain, a conserved central α-crystallin domain, and a flexible C-terminal extension (tedesco2022insightsonhuman pages 2-5, vos2008structuralandfunctional pages 3-5). However, it is notable that HSPB9 exhibits the most divergent protein sequence between mouse and human among orthologous HSPBs, suggesting rapid evolutionary divergence or lineage-specific specialization (tedesco2022insightsonhuman pages 13-14).
HSPB9 expression is highly restricted to testis tissue, specifically in testis germ cells (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5). This tissue-specificity distinguishes HSPB9 from many other family members such as HSPB1, HSPB5, HSPB6, and HSPB8, which show ubiquitous or muscle/neuronal expression patterns (tedesco2022insightsonhuman pages 2-5, tedesco2022insightsonhuman pages 5-6). Among the ten human HSPBs, only HSPB9 and HSPB10 display testis-restricted expression (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3).
Within the testis, HSPB9 expression varies during different stages of spermatogenesis, suggesting a potential developmental role in male germ cell maturation (tedesco2022insightsonhuman pages 13-14). However, the precise temporal and spatial expression pattern throughout spermatogenic stages has not been comprehensively mapped, and the functional significance of this developmental regulation remains unknown.
HSPB9 has been classified as a cancer/testis antigen (CT51) because, while normally restricted to testis, it has been detected in certain tumor types (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3). Cancer/testis antigens are proteins that are typically expressed only in immune-privileged testis tissue but become aberrantly expressed in various cancers, making them potential targets for cancer immunotherapy. However, the specific tumor types expressing HSPB9, the frequency of expression, and any functional role in tumorigenesis have not been systematically investigated (tedesco2022insightsonhuman pages 13-14).
HSPB9 has been reported to localize to both the cytosol and nucleus in testis germ cells (vos2008structuralandfunctional pages 3-3, sun2005smallheatshock pages 8-9). Interestingly, HSPB9 lacks a canonical nuclear localization signal (NLS), suggesting that its nuclear translocation may depend on interaction with other proteins (sun2005smallheatshock pages 8-9). This dual localization pattern is potentially significant, as it may indicate multiple functional roles in different cellular compartments during spermatogenesis, though the functional significance of nuclear versus cytoplasmic localization remains unexplored.
The most well-documented molecular interaction of HSPB9 is with TCTEL1 (also known as DynLT1 or DYNLT1), a light chain subunit of the dynein motor protein complex (vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5). This interaction occurs through the C-terminal region of HSPB9 (vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5). Dynein is a microtubule-based motor protein complex involved in intracellular transport, including vesicle trafficking, organelle positioning, and chromosome movement during cell division.
The interaction with the dynein subunit suggests that HSPB9 may play a role in cellular transport processes during spermatogenesis (vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5). Given that the dynein complex is critical for various aspects of sperm development, including nuclear shaping, acrosome formation, and flagellar assembly, HSPB9 could potentially regulate these transport-dependent processes. However, this remains entirely speculative, as no functional studies have been performed to validate this hypothesis or identify the specific transport processes that might involve HSPB9 (tedesco2022insightsonhuman pages 13-14).
The lack of a nuclear localization signal in HSPB9, combined with its nuclear presence and interaction with dynein components, raises the possibility that TCTEL1/DynLT1 binding may facilitate HSPB9 nuclear import (sun2005smallheatshock pages 8-9). This would be consistent with known functions of dynein light chains in mediating protein-protein interactions beyond their canonical motor functions.
As a member of the small heat shock protein family, HSPB9 is predicted to function as an ATP-independent molecular chaperone capable of binding to partially unfolded or misfolded proteins to prevent their aggregation (tedesco2022insightsonhuman pages 2-5, vos2008structuralandfunctional pages 3-5). This "holdase" activity is characteristic of sHSPs, which stabilize substrate proteins in a folding-competent state for subsequent processing by ATP-dependent chaperones such as HSP70 or by degradation pathways (vos2008structuralandfunctional pages 3-5).
Small heat shock proteins typically function as large oligomeric assemblies, and the equilibrium between different oligomeric states (dimers, tetramers, and larger complexes) is a key regulatory mechanism for their chaperone activity (vos2008structuralandfunctional pages 3-5). However, no studies have examined HSPB9 oligomerization status, quaternary structure, or the influence of oligomeric state on potential chaperone function (tedesco2022insightsonhuman pages 13-14).
Beyond the interaction with TCTEL1/DynLT1, no client proteins or substrates for HSPB9 have been identified (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3). Unlike better-characterized family members such as HSPB1 and HSPB5, which have well-defined roles in protecting cytoskeletal proteins, preventing apoptosis, and maintaining proteostasis (tedesco2022insightsonhuman pages 2-5, tedesco2022insightsonhuman pages 5-6, tedesco2022insightsonhuman pages 9-10), HSPB9 lacks any experimental validation of chaperone activity or substrate repertoire.
No specific biochemical pathways or signaling cascades involving HSPB9 have been characterized (tedesco2022insightsonhuman pages 13-14). Unlike other HSPBs that participate in well-defined processes—such as HSPB1 in stress response and cytoskeletal maintenance, HSPB5 in lens transparency and muscle function, HSPB6 in smooth muscle relaxation, HSPB7 in cardiac development, or HSPB8 in chaperone-assisted selective autophagy (CASA)—HSPB9 has not been linked to any specific cellular pathway (tedesco2022insightsonhuman pages 2-5, tedesco2022insightsonhuman pages 5-6, tedesco2022insightsonhuman pages 7-8, tedesco2022insightsonhuman pages 9-10, tedesco2022insightsonhuman pages 10-12, tedesco2022insightsonhuman pages 12-13, tedesco2022insightsonhuman pages 13-14).
The potential involvement in dynein-mediated transport suggests a possible role in processes requiring intracellular trafficking during spermatogenesis, but this has not been experimentally tested (vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5). As a cancer/testis antigen, HSPB9 could theoretically participate in tumor immunology or cancer-associated stress responses, but again, no pathway-level studies have been conducted (tedesco2022insightsonhuman pages 13-14).
Given its testis-specific expression and developmental regulation during spermatogenesis, HSPB9 is presumed to play a role in male germ cell development or sperm maturation (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3). Spermatogenesis is a complex process involving dramatic cellular remodeling, chromatin reorganization, and extensive intracellular transport. The interaction with dynein components suggests HSPB9 might participate in transport-dependent aspects of sperm development, but no functional studies have validated this hypothesis.
Unlike some other small heat shock proteins that are strongly induced by heat shock or other cellular stresses, HSPB9 does not appear to be a classical stress-inducible protein (tedesco2022insightsonhuman pages 13-14, vos2008structuralandfunctional pages 3-3). This suggests that its primary role may be developmental or tissue-specific rather than general stress protection.
As of the most recent comprehensive reviews in 2022 and 2023, HSPB9 remains one of the least studied members of the human small heat shock protein family (tedesco2022insightsonhuman pages 13-14, gu2023functionaldiversityof pages 17-18). A 2022 review explicitly states: "To our knowledge, the roles of HSPB9 have not yet been investigated neither in testis nor in tumorigenesis and mutations have not been identified" (tedesco2022insightsonhuman pages 13-14). This assessment has not changed with the most recent literature through 2024.
The following critical questions about HSPB9 remain unanswered:
Primary molecular function: Does HSPB9 function as a bona fide ATP-independent chaperone, and if so, what are its substrate proteins?
Oligomeric organization: What is the quaternary structure of HSPB9, and how does oligomerization regulate its function?
Role in spermatogenesis: What specific processes during sperm development require HSPB9 function? Is it essential for male fertility?
Nuclear function: What is the significance of nuclear localization, and what functions does HSPB9 perform in the nucleus versus cytoplasm?
Dynein interaction: Does the interaction with TCTEL1/DynLT1 regulate transport processes, or does it serve a different function?
Cancer relevance: What is the functional significance of aberrant HSPB9 expression in tumors? Does it contribute to tumorigenesis or represent a bystander effect?
Disease associations: Are there human genetic variants or mutations in HSPB9 associated with male infertility or other phenotypes?
In stark contrast to HSPB9, other family members have been extensively characterized. HSPB1 mutations cause hereditary motor and sensory neuropathies; HSPB5 mutations lead to cataracts, myopathies, and cardiomyopathies; HSPB8 mutations cause distal hereditary motor neuropathy and myofibrillar myopathies (tedesco2022insightsonhuman pages 2-5, tedesco2022insightsonhuman pages 5-6, tedesco2022insightsonhuman pages 10-12, tedesco2022insightsonhuman pages 12-13, tedesco2022insightsonhuman pages 13-14). These proteins have well-defined roles in cytoskeletal maintenance, autophagy regulation, apoptosis inhibition, and stress response (tedesco2022insightsonhuman pages 2-5, tedesco2022insightsonhuman pages 5-6, tedesco2022insightsonhuman pages 7-8, tedesco2022insightsonhuman pages 9-10, tedesco2022insightsonhuman pages 10-12, tedesco2022insightsonhuman pages 12-13). The complete absence of similar characterization for HSPB9 represents a significant gap in our understanding of the small heat shock protein family.
| Category | HSPB9 summary | Evidence |
|---|---|---|
| Approved gene/protein identity | HSPB9 encodes heat shock protein beta-9 in Homo sapiens; alternative names include CT51 and cancer/testis antigen 51. It is a member of the mammalian small heat shock protein (HSPB/HSP20) family. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Protein family / class | Classified as a small heat shock protein (sHSP), i.e., a low-molecular-weight, ATP-independent chaperone family characterized by a conserved α-crystallin domain with variable N- and C-terminal regions. Compared with other HSPBs, HSPB9 is among the least functionally characterized members. | (tedesco2022insightsonhuman pages 2-5, vos2008structuralandfunctional pages 3-5) |
| Molecular weight | Reported molecular mass is 17.5 kDa. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Gene location | Chromosomal location reported as 17q21.2. | (vos2008structuralandfunctional pages 3-3) |
| Domain architecture | UniProt/domain-based annotation and family placement indicate a conserved α-crystallin / Hsp20 domain typical of sHSPs; by family analogy this implies a central conserved domain flanked by more variable termini. | (tedesco2022insightsonhuman pages 2-5, vos2008structuralandfunctional pages 3-5) |
| Alternative names / antigen status | HSPB9 is also called CT51 and has been reported as a cancer/testis antigen (CTA) because it is normally testis-restricted yet detectable in certain tumors. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Tissue expression pattern | Expression is testis-specific/restricted, with expression confined to testis germ cells. Relative to other HSPBs, this is unusual because many HSPBs are ubiquitous or muscle/neuronal enriched, whereas HSPB9 and HSPB10 are testis-specific. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5) |
| Developmental / cell-type expression | Expression varies during spermatogenesis, supporting a likely role in male germ-cell biology, though the precise function remains unproven. | (tedesco2022insightsonhuman pages 14-15) |
| Subcellular localization | Reported localization is cytosol and nucleus. A review also notes that HSPB9 lacks a canonical nuclear localization signal, so nuclear entry may depend on binding partners. | (vos2008structuralandfunctional pages 3-3, sun2005smallheatshock pages 8-9) |
| Known interaction partners | The best-described partner is TCTEL1 / DynLT1 (DYNLT1), a dynein light-chain subunit. Interaction is reported to occur via the C-terminus of HSPB9. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Inferred functional implication of interaction | Because DynLT1/TCTEL1 is part of the dynein transport machinery, the HSPB9 interaction suggests a possible role in intracellular transport-related processes in germ cells and/or tumor cells; however this remains hypothetical rather than experimentally established. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3, sun2005smallheatshock pages 8-9) |
| Oligomerization / biophysical state | Unlike many other HSPBs, studies on HSPB9 oligomerization are missing. This is a major gap because oligomer dynamics usually regulate sHSP chaperone activity. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-5) |
| Chaperone activity | Although family membership implies potential ATP-independent holdase/chaperone behavior, direct experimental evidence for HSPB9 chaperone activity, substrate spectrum, or anti-aggregation capacity is lacking. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-5) |
| Enzymatic activity / substrate specificity | No enzymatic activity is known; HSPB9 is not described as an enzyme. No specific client/substrate proteins have been validated beyond the reported interaction with DynLT1/TCTEL1. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Stress inducibility | Current sources emphasize testis-restricted expression and do not provide clear evidence that HSPB9 is a classic heat-inducible stress protein in the way some other HSPBs are. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Disease / cancer relevance | HSPB9 has been detected in tumors, which underlies its CTA designation, but its role in tumorigenesis has not been investigated in depth and no disease-causing mutations have been identified. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3) |
| Evolutionary note | Among orthologous HSPBs, HSPB9 has been described as having the most divergent sequence between mouse and human, suggesting rapid specialization or lineage-specific divergence. | (tedesco2022insightsonhuman pages 14-15) |
| Comparison with other HSPBs | In contrast to better-studied HSPBs such as HSPB1, HSPB5, HSPB6, HSPB7, and HSPB8, which have defined roles in cytoskeletal maintenance, apoptosis, autophagy, or muscle physiology, HSPB9 lacks equivalent mechanistic characterization. | (tedesco2022insightsonhuman pages 2-5, tedesco2022insightsonhuman pages 7-8, tedesco2022insightsonhuman pages 10-12, tedesco2022insightsonhuman pages 12-13, tedesco2022insightsonhuman pages 14-15) |
| Key current knowledge gaps | Major open questions include: true molecular function, client proteins/substrates, oligomeric organization, whether it acts as a bona fide chaperone, its exact role in spermatogenesis, the significance of nuclear localization, and whether CTA expression in cancer has diagnostic or therapeutic relevance. | (tedesco2022insightsonhuman pages 14-15, vos2008structuralandfunctional pages 3-3, vos2008structuralandfunctional pages 3-5) |
Table: This table compiles the currently known features of human HSPB9/CT51, including molecular properties, expression, localization, interaction data, and major evidence gaps. It is useful because HSPB9 is poorly characterized, so the table distinguishes supported facts from family-based inference and unresolved questions.
HSPB9 represents one of the most poorly characterized human proteins in the otherwise well-studied small heat shock protein family. While its testis-specific expression pattern and cancer/testis antigen status suggest important roles in spermatogenesis and potentially in tumor biology, virtually no functional data exist to support these inferences. The single documented molecular interaction with the dynein light chain TCTEL1/DynLT1 provides a tantalizing clue about potential involvement in intracellular transport, but this has not been experimentally validated.
Future research priorities should include: (1) detailed expression mapping during spermatogenesis, (2) functional studies using knockout models to assess roles in male fertility, (3) biochemical characterization of chaperone activity and substrate specificity, (4) determination of oligomeric structure and regulation, (5) investigation of the functional significance of nuclear localization, and (6) exploration of potential roles in cancer biology. Until such studies are conducted, the function of HSPB9 can only be inferred from its structural features and family membership, with the understanding that these inferences remain speculative and unvalidated.
Recent Literature Note: Despite prioritizing 2023-2024 sources as requested, no recent experimental studies on HSPB9 function were identified, confirming that this protein remains an understudied member of the human proteome requiring future investigation.
References
(tedesco2022insightsonhuman pages 13-14): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(vos2008structuralandfunctional pages 3-3): Michel J. Vos, Jurre Hageman, Serena Carra, and Harm H. Kampinga. Structural and functional diversities between members of the human hspb, hsph, hspa, and dnaj chaperone families. Biochemistry, 47 27:7001-11, Jul 2008. URL: https://doi.org/10.1021/bi800639z, doi:10.1021/bi800639z. This article has 522 citations and is from a peer-reviewed journal.
(vos2008structuralandfunctional pages 3-5): Michel J. Vos, Jurre Hageman, Serena Carra, and Harm H. Kampinga. Structural and functional diversities between members of the human hspb, hsph, hspa, and dnaj chaperone families. Biochemistry, 47 27:7001-11, Jul 2008. URL: https://doi.org/10.1021/bi800639z, doi:10.1021/bi800639z. This article has 522 citations and is from a peer-reviewed journal.
(tedesco2022insightsonhuman pages 2-5): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(tedesco2022insightsonhuman pages 5-6): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(sun2005smallheatshock pages 8-9): Y. Sun and T. H. MacRae. Small heat shock proteins: molecular structure and chaperone function. Cellular and Molecular Life Sciences CMLS, 62:2460-2476, Sep 2005. URL: https://doi.org/10.1007/s00018-005-5190-4, doi:10.1007/s00018-005-5190-4. This article has 650 citations.
(tedesco2022insightsonhuman pages 9-10): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(tedesco2022insightsonhuman pages 7-8): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(tedesco2022insightsonhuman pages 10-12): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(tedesco2022insightsonhuman pages 12-13): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(gu2023functionaldiversityof pages 17-18): Chaoguang Gu, Xinyi Fan, and Wei Yu. Functional diversity of mammalian small heat shock proteins: a review. Cells, 12:1947, Jul 2023. URL: https://doi.org/10.3390/cells12151947, doi:10.3390/cells12151947. This article has 49 citations.
(tedesco2022insightsonhuman pages 14-15): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.